Immediate vs On-Demand Maternal Oral Full-Feeding After Unplanned Cesarean Section During Labor: A Randomized Controlled Trial
Abstract
BACKGROUND
The adoption of enhanced recovery pathways after cesarean section (ERAC) is increasing but evidence supporting individual interventions having a specific benefit to ERAC is lacking. One key element in ERAC is early oral intake. Maternal complications are more frequent in unplanned cesarean section. In planned cesarean, immediate full-feeding enhances recovery but impact in unplanned cesarean during labor is not known.
OBJECTIVE
To evaluate immediate compared to on-demand oral full-feeding after unplanned cesarean in labor on vomiting and maternal satisfaction.
STUDY DESIGN
A randomized controlled trial was conducted in a university hospital. The first participant was enrolled on October 20 2021, the last on January 14 2023 and follow up was completed on January 16 2023.. Women were assessed for full eligibility on arrival at the postnatal ward after their unplanned cesarean. Primary outcomes were vomiting in the first 24 hours (non-inferiority hypothesis, 5% non-inferiority margin) and maternal satisfaction with their feeding regimen (superiority hypothesis). Secondary outcomes include time to first feed, food and beverage quantum consumed at first feed, nausea, vomiting and bloating at 30 minutes after first feed, then at 8, 16, and 24 hours post-operation, and at hospital discharge, parenteral anti-emetic and opiate analgesia use, first breastfeeding and satisfactory breastfeeding, bowel sound, flatus, second meal, cessation of intravenous fluid, removal of…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 501 participants or records.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.